알츠하이머병,
[페나메이트 계열 NSAID(소염진통제)의 알츠하이머병 치료 가능성을 보여주는 Nature Communications 논문]
[페나메이트 계열 NSAID(소염진통제)의 알츠하이머병 치료 가능성을 보여주는 Nature Communications 논문]
The new drug approval process is expensive and arduous: 10 years and $1 billion is typical for a new drug to be developed…
Un antiinflamatorio podría tratar eficazmente la enfermedad de…
Researchers at The University of Manchester have identified an anti-inflammatory drug that has completely reversed memory loss…